BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hirode G, Saab S, Wong RJ. Trends in the Burden of Chronic Liver Disease Among Hospitalized US Adults. JAMA Netw Open 2020;3:e201997. [PMID: 32239220 DOI: 10.1001/jamanetworkopen.2020.1997] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 9.5] [Reference Citation Analysis]
Number Citing Articles
1 Dimartini AF, Leggio L, Singal AK. Barriers to the management of alcohol use disorder and alcohol-associated liver disease: strategies to implement integrated care models. The Lancet Gastroenterology & Hepatology 2022;7:186-95. [DOI: 10.1016/s2468-1253(21)00191-6] [Reference Citation Analysis]
2 Blaszkiewicz J, Duncan SA. Advancements in Disease Modeling and Drug Discovery Using iPSC-Derived Hepatocyte-like Cells. Genes 2022;13:573. [DOI: 10.3390/genes13040573] [Reference Citation Analysis]
3 Cachay ER, Mena A, Morano L, Benitez L, Maida I, Mendoza C, Hill L, Torriani F, Soriano V, Mathews WC; HCV-HIV Transatlantic Research Network (HCV-TREN). Hepatitis C Treatment Outcomes in Persons With HIV and Decompensated Cirrhosis Using a Collaborative Multidisciplinary HIV-Centered Approach. J Int Assoc Provid AIDS Care 2021;20:23259582211024771. [PMID: 34132142 DOI: 10.1177/23259582211024771] [Reference Citation Analysis]
4 Rustgi VK, Li Y, John T, Catalano C, Elsaid MI. Health Care Resource Use and Cost Burden of Chronic Kidney Disease in Patients With Chronic Liver Disease: A Real-World Claims Analysis. Hepatol Commun. 2020;4:1404-1418. [PMID: 33024912 DOI: 10.1002/hep4.1573] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
5 Dahiya DS, Kichloo A, Shaka H, Singh J, Singh G, Wani F, Masudi S, Koul H, Pisipati S. Hepatopulmonary Syndrome: A Nationwide Analysis of Epidemiological Trends and Outcomes From 2012 to 2018. Gastroenterology Res 2021;14:252-8. [PMID: 34527095 DOI: 10.14740/gr1448] [Reference Citation Analysis]
6 Calcaterra SL, McBeth L, Keniston AM, Burden M. The Development and Implementation of a Hospitalist-Directed Addiction Medicine Consultation Service to Address a Treatment Gap. J Gen Intern Med 2021. [PMID: 34013473 DOI: 10.1007/s11606-021-06849-8] [Reference Citation Analysis]
7 Bhandari R, Khaliq K, Ravat V, Kaur P, Patel RS. Chronic Alcoholic Liver Disease and Mortality Risk in Spontaneous Bacterial Peritonitis: Analysis of 6,530 Hospitalizations. Cureus 2020;12:e8189. [PMID: 32566430 DOI: 10.7759/cureus.8189] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Singal AK, Arsalan A, Dunn W, Arab JP, Wong RJ, Kuo YF, Kamath PS, Shah VH. Alcohol-associated liver disease in the United States is associated with severe forms of disease among young, females and Hispanics. Aliment Pharmacol Ther 2021;54:451-61. [PMID: 34247424 DOI: 10.1111/apt.16461] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Song IA, Jang ES, Oh TK. Validation of Dynamic Aspartate-to-Alanine Aminotransferase Ratio for Predicting Liver Disease Mortality. Hepatol Commun 2021. [PMID: 34713990 DOI: 10.1002/hep4.1844] [Reference Citation Analysis]
10 Mikolajczyk AE, Zilberstein N, McConville JF, Pan A, Aronsohn AI, Te HS, Reddy G, Paul S, Pillai A, Charlton M, Farnan JM. Mandatory Hepatology Education for Internal Medicine Residents: Long-Term Effects and Implications for Workforce Needs. Hepatol Commun 2021;5:1953-63. [PMID: 34558840 DOI: 10.1002/hep4.1792] [Reference Citation Analysis]
11 Kappus MR, Rahimi RS, Volk ML. Measuring the Toll of Acute Illness-Derived Frailty in Decompensated Cirrhosis. Liver Transpl 2021. [PMID: 34338440 DOI: 10.1002/lt.26249] [Reference Citation Analysis]
12 Proctor DD. Concise Commentary: Ill Preparation for Managing Liver Illness Among Incoming Medical Residents. Dig Dis Sci 2021. [PMID: 34365538 DOI: 10.1007/s10620-021-07195-9] [Reference Citation Analysis]
13 Serper M. Monitoring for Ascites in Cirrhosis Using Patient-Generated Health Data: No Longer a Remote Possibility. Dig Dis Sci 2021. [PMID: 34008115 DOI: 10.1007/s10620-021-07020-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Yu S, Ericson M, Fanjul A, Erion DM, Paraskevopoulou M, Smith EN, Cole B, Feaver R, Holub C, Gavva N, Horman SR, Huang J. Genome-wide CRISPR Screening to Identify Drivers of TGF-β-Induced Liver Fibrosis in Human Hepatic Stellate Cells. ACS Chem Biol 2022. [PMID: 35274923 DOI: 10.1021/acschembio.2c00006] [Reference Citation Analysis]
15 Deliwala SS, Hussain M, Ponnapalli A, Igbinedion SO, Bachuwa G, Bansal A. Accelerated balloon-retrograde transvenous obliteration (BRTO): an effective tool in the Arsenal against isolated gastric varices (IGV). BMJ Case Rep 2021;14:e244405. [PMID: 34489255 DOI: 10.1136/bcr-2021-244405] [Reference Citation Analysis]
16 Wong RJ, Jain MK, Therapondos G, Niu B, Kshirsagar O, Thamer M. Antiviral Therapy Reduces Risk of Cirrhosis in Noncirrhotic HBV Patients Among 4 Urban Safety-Net Health Systems. Am J Gastroenterol 2021;116:1465-75. [PMID: 33661148 DOI: 10.14309/ajg.0000000000001195] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Minhas AMK, Bhopalwala HM, Dewaswala N, Salah HM, Khan MS, Shahid I, Biegus J, Lopes RD, Pandey A, Fudim M. Association of Non-Alcoholic Fatty Liver Disease with In-Hospital Outcomes in Primary Heart Failure Hospitalizations with Reduced or Preserved Ejection Fraction. Current Problems in Cardiology 2022. [DOI: 10.1016/j.cpcardiol.2022.101199] [Reference Citation Analysis]
18 Lin JA, Gardner JM, Kolli KP, Cook AC. Surgical, Interventional, and Medical Palliation of Portal Hypertension. Am Surg 2020;86:1467-72. [PMID: 33153284 DOI: 10.1177/0003134820965947] [Reference Citation Analysis]
19 Kim D, Adeniji N, Latt N, Kumar S, Bloom PP, Aby ES, Perumalswami P, Roytman M, Li M, Vogel AS, Catana AM, Wegermann K, Carr RM, Aloman C, Chen V, Rabiee A, Sadowski B, Nguyen V, Dunn W, Chavin K, Zhou K, Lizaola-Mayo B, Moghe A, Debes J, Lee TH, Branch A, Viveiros K, Chan W, Chascsa D, Kwo P, Dhanasekaran R. Predictors of Outcomes of COVID-19 in Patients with Chronic Liver Disease: US Multi-center Study. Clin Gastroenterol Hepatol. 2020;. [PMID: 32950749 DOI: 10.1016/j.cgh.2020.09.027] [Cited by in Crossref: 32] [Cited by in F6Publishing: 38] [Article Influence: 16.0] [Reference Citation Analysis]
20 Wong RJ, Hirode G. The Effect of Hospital Safety-Net Burden and Patient Ethnicity on In-Hospital Mortality Among Hospitalized Patients With Cirrhosis. J Clin Gastroenterol 2021;55:624-30. [PMID: 33136780 DOI: 10.1097/MCG.0000000000001452] [Reference Citation Analysis]
21 Da BL, Im GY, Schiano TD. Coronavirus Disease 2019 Hangover: A Rising Tide of Alcohol Use Disorder and Alcohol-Associated Liver Disease. Hepatology. 2020;72:1102-1108. [PMID: 32369624 DOI: 10.1002/hep.31307] [Cited by in Crossref: 57] [Cited by in F6Publishing: 70] [Article Influence: 28.5] [Reference Citation Analysis]
22 Roberts SB, Hansen BE, Shin S, Abrahamyan L, Lapointe-Shaw L, Janssen HLA, Razak F, Verma AA, Hirschfield GM. Internal medicine hospitalisations and liver disease: a comparative disease burden analysis of a multicentre cohort. Aliment Pharmacol Ther 2021;54:689-98. [PMID: 34181776 DOI: 10.1111/apt.16488] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
23 Singal AK, Mathurin P. Diagnosis and Treatment of Alcohol-Associated Liver Disease: A Review. JAMA 2021;326:165-76. [PMID: 34255003 DOI: 10.1001/jama.2021.7683] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Burkholder DA, Moran IJ, DiBattista JV, Lok AS, Parikh ND, Chen VL. Accuracy of International Classification of Diseases-10 Codes for Cirrhosis and Portal Hypertensive Complications. Dig Dis Sci 2021. [PMID: 34674069 DOI: 10.1007/s10620-021-07282-x] [Reference Citation Analysis]
25 Ogino N, Ikeda F, Namba S, Ohkubo S, Nishimura T, Okada H, Hirohata S, Suganuma N, Ogino K. Plasma Arginase-1 Level Is Associated with the Mental Status of Outpatients with Chronic Liver Disease. Diagnostics (Basel) 2021;11:317. [PMID: 33669265 DOI: 10.3390/diagnostics11020317] [Reference Citation Analysis]
26 Moon AM, Curtis B, Mandrekar P, Singal AK, Verna EC, Fix OK. Alcohol-Associated Liver Disease Before and After COVID-19-An Overview and Call for Ongoing Investigation. Hepatol Commun 2021. [PMID: 34222743 DOI: 10.1002/hep4.1747] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]